Crossmark

Immunogenicity Risk Assessment for PEGylated Therapeutics

Crossref DOI link: https://doi.org/10.1208/s12248-020-0420-0

Published Online: 2020-01-28

Published Print: 2020-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mora, Johanna R.

White, Joleen T.

DeWall, Stephen L.
License Information

Text and Data Mining valid from 2020-01-28

Version of Record valid from 2020-01-28
More Information

Article History

Received: 31 October 2019

Accepted: 7 January 2020

First Online: 28 January 2020